Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04887831 |
|---|---|
| Brief Title: | Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab (PRESERVE3) |
| First Submitted : | May 5, 2021 |
| First Submitted that Met QC Criteria : | May 13, 2021 |
| First Posted : | May 14, 2021 |
| Last Update Submitted that Met QC Criteria : | January 24, 2023 |
| Last Update Posted : | January 26, 2023 |